Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aloe Vera for Interstitial Cystitis
NCT04734106Phase 1Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 2025
- Primary completion
- Apr 2027
- Modality
- PE (Plant Extract), Dietary Supplement
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in interstitial cystitis (IC) comparing Aloe Vera with Placebo (2 arms). Primary endpoint: Adverse Events at 16 weeks. Started Feb 2025; status: recruiting.
02
Drugs
aloe vera
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT04734106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04734106.